Karina
Analyst
Truist
Equibles does not estimate personal net worth.
About Karina
Karina is recorded as Analyst at Truist. Karina has spoken on 1 earnings call across 1 company, most recently for Arcus Biosciences, Inc. on May 6, 2025. The companies whose calls Karina spoke on are classified in the Healthcare sector.
Karina on recent calls
“So, beyond the AstraZeneca study with a bullish stomach, are there any plans to initiate registrational studies, potentially in combinations with PD-1s or ZAMDA in Frontline?”
Affiliation history
-
Truist
Analyst
Transcript header (unverified)
Current